BRUSSELS, Dec. 1 (Xinhua) -- Pharmaceutical firms Pfizer and BioNTech, as well as their competitor Moderna, have filed applications for approval of their COVID-19 vaccines, the European Medicines Agency (EMA) said on Tuesday.
The firms seek "conditional marketing authorization" for their vaccines. The authorization will be granted after the agency finds the submitted data robust enough to guarantee quality, safety and effectiveness.
